EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy

Andrea Ziblat, Brendan L Horton, Emily F Higgs, Ken Hatogai, Anna Martinez, Jason W Shapiro, Danny E C Kim, YuanYuan Zha, Randy F Sweis, Thomas F Gajewski

Cell Reports · 2024-05 · 43 (5) · 114141

DOI: 10.1016/j.celrep.2024.114141 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024-05. Verfasst von Andrea Ziblat und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA. Hauptthemen laut MEDLINE: B7-H1 Antigen, Basic-Leucine Zipper Transcription Factors, CD8-Positive T-Lymphocytes, Dendritic Cells. Die Arbeit wurde bisher 35-mal zitiert (Crossref) und nennt 95 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: NCI NIH HHS, NIAID NIH HHS, NICHD NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

B7-H1 AntigenBasic-Leucine Zipper Transcription FactorsCD8-Positive T-LymphocytesDendritic CellsProgrammed Cell Death 1 ReceptorRepressor ProteinsTumor MicroenvironmentAnimalsHumansMice4-1BB LigandCell Line, TumorImmune Checkpoint InhibitorsMice, Inbred C57BLSignal TransductionTumor Necrosis Factor Receptor Superfamily, Member 9

Stichwörter der Autor:innen

4-1BB4-1BBLBatf3-lineage dendritic cellsCD8(+) T cellsCP: CancerCP: ImmunologyDC1sPD-1/PD-L1 blockadeimmunotherapyimmunotherapy efficacyspatial transcriptomics

Substanzen

4-1BB LigandB7-H1 AntigenBasic-Leucine Zipper Transcription FactorsBATF3 protein, humanImmune Checkpoint InhibitorsProgrammed Cell Death 1 ReceptorRepressor ProteinsSNFT protein, mouseTumor Necrosis Factor Receptor Superfamily, Member 9

Autor:innen und Institutionen

  • Department of Pathology, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA.
  • Center for Research Informatics, University of Chicago, Chicago, IL 60637, USA.
  • Human Immunological Monitoring Facility, University of Chicago, Chicago, IL 60637, USA.
  • Department of Medicine, University of Chicago, Chicago, IL 60612, USA.
  • Department of Pathology, Section of Hematology/Oncology, University of Chicago, Chicago, IL 60637, USA; Department of Medicine, University of Chicago, Chicago, IL 60612, USA. Electronic address: tgajewsk@bsd.uchicago.ed…

Förderung

  • NCI NIH HHS
  • NIAID NIH HHS
  • NICHD NIH HHS
  • NIH

Zitieren

APA

Ziblat, A., Horton, B. L., Higgs, E. F., Hatogai, K., Martinez, A., Shapiro, J. W., Kim, D. E. C., Zha, Y., Sweis, R. F., & Gajewski, T. F. (2024). Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy. Cell Reports, 43(5), 114141. https://doi.org/10.1016/j.celrep.2024.114141

Vancouver

Ziblat A, Horton BL, Higgs EF, Hatogai K, Martinez A, Shapiro JW, et al. Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy. Cell Reports. 2024;43(5):114141. doi:10.1016/j.celrep.2024.114141

BibTeX
@article{Ziblat2024,
  author = {Ziblat, Andrea and Horton, Brendan L and Higgs, Emily F and Hatogai, Ken and Martinez, Anna and Shapiro, Jason W and Kim, Danny E C and Zha, YuanYuan and Sweis, Randy F and Gajewski, Thomas F},
  title = {Batf3+ DCs and the 4-1BB/4-1BBL axis are required at the effector phase in the tumor microenvironment for PD-1/PD-L1 blockade efficacy},
  journal = {Cell Reports},
  year = {2024},
  volume = {43},
  number = {5},
  pages = {114141},
  doi = {10.1016/j.celrep.2024.114141}
}
Kostenlos starten →